Microphysiological systems will revolutionize experimental biology and medicine
2014-09-02
(Press-News.org) The Annual Thematic issue of Experimental Biology and Medicine that appears in September 2014 is devoted to "The biology and medicine of microphysiological systems" and describes the work of scientists participating in the Microphysiological Systems Program directed by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and funded in part by the NIH Common Fund. The Defense Advanced Research Projects Agency (DARPA) and the Food and Drug Administration (FDA) are collaborating with the NIH in the program. Fourteen of the research teams supported by the program have contributed papers and represent more than 20 institutions, including Baylor College of Medicine, Columbia University, Cornell University, Duke University, Johns Hopkins University, Massachusetts General Hospital and Harvard Medical School, the Massachusetts Institute of Technology, Northwestern University, Nortis, Inc., the University of California, Irvine, the University of Central Florida, the University of Pennsylvania, the University of Pittsburgh, the University of Texas Medical Branch, and Vanderbilt University.
Dr. John P. Wikswo, founding Director of the Vanderbilt Institute for Integrative Biosystems Research and Education and Editor of the Thematic Issue, explains in his introductory review that microphysiological systems (MPS) – often called "organs-on-chips" – are interacting sets of constructs of human cells. Each construct is designed to recapitulate the structure and function of a human organ or organ region, and when connected in an MPS, they may provide in vitro models with great physiological accuracy for studying cell-cell, drug-cell, drug-drug, and organ-drug interactions. The papers in the Thematic Issue describe the ongoing development of MPS as in vitro models for bone and cartilage, brain, gastrointestinal tract, lung, liver, microvasculature, reproductive tract, skeletal muscle, and skin, as well as the interconnection of organs-on-chips to support physiologically based pharmacokinetics and drug discovery and screening, and the microscale technologies that regulate stem cell differentiation. Wikswo notes that the initial motivation for creating MPS was to increase the efficiency and human relevance of pharmaceutical development and testing. Obvious applications of the technology include studies of the effect of environmental toxins on humans, identification, characterization, and neutralization of chemical and biological weapons, controlled studies of the microbiome and infectious disease that cannot be conducted in humans, controlled differentiation of induced pluripotent stem cells into specific adult cellular phenotypes, and studies of the dynamics of metabolism and signaling within and between human organs.
In his commentary for the Thematic Issue, Dr. William Slikker Jr., Director of the FDA's National Center for Toxicological Research, writes "The goal [is] to accomplish this human-on-a-chip capability in a decade – a feat somewhat equivalent to the moon shot of the 1960s – and, like landing man on the moon, simulating a human being from a physiological/toxicological perspective may indeed be possible. But even if ultimately it is not, a great deal of fundamental biology and physiology will be elucidated along the way, much to the benefit of our understanding of human health and disease processes."
Dr. D. Lansing Taylor, Director of the University of Pittsburgh Drug Discovery Institute, says "The Thematic Issue brings together the leaders of the field of Human-on-a-Chip to discuss the early successes, great potential and continuing challenges of this emerging field. For complete success, we must integrate advances in multiple technical areas, including microfluidics, stem cell biology, 3D microstructures/matrices, multi-cell engineering, universal blood substitutes, and a variety of biological detection technologies, database tools, and computational modeling for both single and a combination of organ systems. Success will be transformative for basic biology, physiology, pharmacology, toxicology and medicine, as well as the new field of quantitative systems pharmacology, where iterative experimentation and computational modeling of disease models and pharmacodynamics and pharmacokinetics are central. The focus is to create physiologically relevant, robust, reproducible and cost-effective tools for the scientific community."
Dr. Danilo A. Tagle, NIH NCATS Associate Director for Special Initiatives, adds "This special issue highlights the exciting and rapid progress towards development of MPS for drug safety and efficacy testing. Much progress has been achieved in the two years of the program, and these articles describe the efforts by an outstanding group of investigators towards realizing the goal of fully integrated 10 organ systems. There are tremendous scientific opportunities and discoveries that could be had in the future utility of these tissues/organs on chips."
Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, agrees. "We are proud to publish this Thematic Issue dedicated to "The biology and medicine of microphysiological systems." Dr. John Wikswo is to be congratulated for assembling an exceptional group of researchers who are leaders in the field of MPS and the many uses of this exciting technology. MPS has the potential to revolutionize experimental biology and medicine. Because of the great importance and promise of organs-on-chips and MPS technology, it has now become a major area of emphasis for the Systems Biology category of Experimental Biology and Medicine."
INFORMATION:
Experimental Biology and Medicine is a journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903. Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership visit http://www.sebm.org. If you are interested in publishing in the journal please visit http://ebm.sagepub.com/.
ELSE PRESS RELEASES FROM THIS DATE:
An uphill climb for mountain species?
2014-09-02
A recently published paper provides a history of scientific research on mountain ecosystems, looks at the issues threatening wildlife in these systems, and sets an agenda for biodiversity conservation throughout the world's mountain regions.
The paper, "Mountain gloom and mountain glory revisited: A survey of conservation, connectivity, and climate change in mountain regions," appears online in the Journal of Mountain Ecology. Authors are Charles C. Chester of Tufts University, Jodi A. Hilty of the Wildlife Conservation Society, and Lawrence S. Hamilton of World Commission ...
Sabotage as therapy: Aiming lupus antibodies at vulnerable cancer cells
2014-09-02
New Haven, Conn. — Yale Cancer Center researchers may have discovered a new way of harnessing lupus antibodies to sabotage cancer cells made vulnerable by deficient DNA repair.
The findings were published recently in Nature's journal Scientific Reports.
The study, led by James E. Hansen, M.D., assistant professor of therapeutic radiology at Yale School of Medicine, found that cancer cells with deficient DNA repair mechanisms (or the inability to repair their own genetic damage) were significantly more vulnerable to attack by lupus antibodies.
"Patients with lupus ...
Seatbelt laws encourage obese drivers to buckle up
2014-09-02
CHAMPAIGN, Ill. — Obesity is associated with many health risks, including heart disease and diabetes, but University of Illinois researchers have found a possible way to mitigate one often-overlooked risk: not buckling up in the car.
A new study led by Sheldon H. Jacobson, a professor of computer science and of mathematics, found that increasing the obesity rates are associated with a decrease in seatbelt usage. However, these effects can be mitigated when seatbelt laws are in effect.
"Primary seatbelt laws lead to increased use of seatbelts," Jacobson said. "On the ...
Melatonin does not reduce delirium in elderly patients having acute hip surgery
2014-09-02
Melatonin supplements do not appear to lessen delirium in elderly people undergoing surgery for hip fractures, indicates a new trial published in CMAJ (Canadian Medical Association Journal)
Many older patients in hospital experience delirium, with disturbances in their sleep–wake cycle. Antipsychotic medications used to reduce symptoms have serious adverse effects, leading the US Food and Drug Administration to warn against their use. Benzodiazepines are also used, although they are known to cause or aggravate delirium. A lack of melatonin may be one factor underlying ...
Changing microbial dynamics in the wake of the Macondo blowout
2014-09-02
In an article in the September issue of BioScience, Samantha Joye and colleagues describe Gulf of Mexico microbial communities in the aftermath of the 2010 Macondo blowout. The authors describe revealing population-level responses of hydrocarbon-degrading microbes to the unprecedented deepwater oil plume.
The spill provided a unique opportunity to study the responses of indigenous microbial communities to a substantial injection of hydrocarbons. Surveys of genetic identifiers within cells known as ribosomal RNA and analyses relying on modern techniques including metagenomics, ...
Humiliation tops list of mistreatment toward med students
2014-09-02
Each year thousands of students enroll in medical schools across the country. But just how many feel they've been disrespected, publicly humiliated, ridiculed or even harassed by their superiors at some point during their medical education?
Recently, researchers at Michigan State University were the first to analyze 12 years worth of national survey data from the Association of American Medical Colleges, or AAMC, questioning graduating students about their medical school experience during the clinical portion of their education.
They found that up to 20 percent of ...
Early cerebellum injury hinders neural development, possible root of autism
2014-09-02
A brain region largely known for coordinating motor control has a largely overlooked role in childhood development that could reveal information crucial to understanding the onset of autism, according to Princeton University researchers.
The cerebellum — an area located in the lower rear of the brain — is known to process external and internal information such as sensory cues that influence the development of other brain regions, the researchers report in the journal Neuron. Based on a review of existing research, the researchers offer a new theory that an injury to the ...
Can data motivate hospital leaders to improve care transitions?
2014-09-02
What happens when you are hospitalized, but your outpatient doctor does not know? Or when you arrive at the office for follow-up care, but your doctor does not have the right information about your hospital stay? Missing or incomplete communication from hospitals to outpatient primary care physicians (PCPs) can contribute to poor experiences and lead to hospital readmissions.
However, a new study shows that implementing guidelines can improve hospitals' communication during patient care transitions. Researchers from Healthcentric Advisors collaborated with Rhode Island ...
Molecular probes permit doctors to detect diabetic retinopathy before vision fails
2014-09-02
A new study published in the September issue of The FASEB Journal, http://www.fasebj.org, identifies a novel strategy to diagnose the leading cause of blindness in adults, diabetic retinopathy, before irreversible structural damage has occurred. This advance involves quantifying the early molecular changes caused by diabetes on the endothelium of retinal vessels. Using new probes developed by scientists, they were able to distinguish the early molecular development of diabetic retinopathy.
"My goal is to establish a versatile clinical tool that alerts of a disease process ...
Research in rodents suggests potential for 'in body' muscle regeneration
2014-09-02
Winston-Salem, N.C. – Sept. 2, 2014 – What if repairing large segments of damaged muscle tissue was as simple as mobilizing the body's stem cells to the site of the injury? New research in mice and rats, conducted at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, suggests that "in body" regeneration of muscle tissue might be possible by harnessing the body's natural healing powers.
Reporting online ahead of print in the journal Acta Biomaterialia, the research team demonstrated the ability to recruit stem cells that can form muscle tissue to ...